Literature DB >> 17287301

Sarcopaenia in chronic obstructive pulmonary disease.

Michael C Steiner.   

Abstract

Entities:  

Mesh:

Year:  2007        PMID: 17287301      PMCID: PMC2111238          DOI: 10.1136/thx.2006.067009

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  39 in total

1.  Characterization of nonresponse to high caloric oral nutritional therapy in depleted patients with chronic obstructive pulmonary disease.

Authors:  E C Creutzberg; A M Schols; C A Weling-Scheepers; W A Buurman; E F Wouters
Journal:  Am J Respir Crit Care Med       Date:  2000-03       Impact factor: 21.405

Review 2.  Effects of ageing and human whole body and muscle protein turnover.

Authors:  J Dorrens; M J Rennie
Journal:  Scand J Med Sci Sports       Date:  2003-02       Impact factor: 4.221

3.  Prognostic value of nutritional status in chronic obstructive pulmonary disease.

Authors:  C Landbo; E Prescott; P Lange; J Vestbo; T P Almdal
Journal:  Am J Respir Crit Care Med       Date:  1999-12       Impact factor: 21.405

4.  Inflammatory response and body composition in chronic obstructive pulmonary disease.

Authors:  A A Eid; A A Ionescu; L S Nixon; V Lewis-Jenkins; S B Matthews; T L Griffiths; D J Shale
Journal:  Am J Respir Crit Care Med       Date:  2001-10-15       Impact factor: 21.405

5.  Nutritional intervention in COPD: a systematic overview.

Authors:  I Ferreira; D Brooks; Y Lacasse; R Goldstein
Journal:  Chest       Date:  2001-02       Impact factor: 9.410

6.  Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease.

Authors:  Elisabeth B Swallow; Diana Reyes; Nicholas S Hopkinson; William D-C Man; Raphaël Porcher; Edward J Cetti; Alastair J Moore; John Moxham; Michael I Polkey
Journal:  Thorax       Date:  2006-11-07       Impact factor: 9.139

7.  Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease.

Authors:  Karine Marquis; Richard Debigaré; Yves Lacasse; Pierre LeBlanc; Jean Jobin; Guy Carrier; François Maltais
Journal:  Am J Respir Crit Care Med       Date:  2002-09-15       Impact factor: 21.405

Review 8.  Muscle strength, disability and mortality.

Authors:  T Rantanen
Journal:  Scand J Med Sci Sports       Date:  2003-02       Impact factor: 4.221

9.  Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I.

Authors:  M A Spruit; R Gosselink; T Troosters; A Kasran; G Gayan-Ramirez; P Bogaerts; R Bouillon; M Decramer
Journal:  Thorax       Date:  2003-09       Impact factor: 9.139

10.  Nutritional enhancement of exercise performance in chronic obstructive pulmonary disease: a randomised controlled trial.

Authors:  M C Steiner; R L Barton; S J Singh; M D L Morgan
Journal:  Thorax       Date:  2003-09       Impact factor: 9.139

View more
  4 in total

Review 1.  Resistance Training before, during, and after COVID-19 Infection: What Have We Learned So Far?

Authors:  Paulo Gentil; Claudio Andre Barbosa de Lira; Carlos Alexandre Vieira; Rodrigo Ramirez-Campillo; Amir Hossein Haghighi; Filipe Manuel Clemente; Daniel Souza
Journal:  Int J Environ Res Public Health       Date:  2022-05-23       Impact factor: 4.614

2.  Associations between isokinetic muscle strength, high-level functional performance, and physiological parameters in patients with chronic obstructive pulmonary disease.

Authors:  Scotty J Butcher; Brendan J Pikaluk; Robyn L Chura; Mark J Walkner; Jonathan P Farthing; Darcy D Marciniuk
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-08-22

3.  Sarcopenia correlates with systemic inflammation in COPD.

Authors:  Min Kwang Byun; Eun Na Cho; Joon Chang; Chul Min Ahn; Hyung Jung Kim
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-02-20

4.  Skeletal Myosteatosis is Associated with Systemic Inflammation and a Loss of Muscle Bioenergetics in Stable COPD.

Authors:  Hans Lennart Persson; Apostolos Sioutas; Magnus Kentson; Petra Jacobson; Peter Lundberg; Olof Dahlqvist Leinhard; Mikael Fredrik Forsgren
Journal:  J Inflamm Res       Date:  2022-08-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.